Global Immunology Drug Sales Market Report 2021

1 Immunology Drug Market Overview

• 1.1 Immunology Drug Product Scope
• 1.2 Immunology Drug Segment by Type
  • 1.2.1 Global Immunology Drug Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Monoclonal Antibodies (mAb)
  • 1.2.3 Antibody Drug Conjugates
  • 1.2.4 Interferon and Cytokine therapies
  • 1.2.5 Immunosuppressive medication
• 1.3 Immunology Drug Segment by Application
  • 1.3.1 Global Immunology Drug Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Cancer Research Centers and Institutes
• 1.4 Immunology Drug Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Immunology Drug Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Immunology Drug Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Immunology Drug Price Trends (2016-2027)

2 Immunology Drug Estimates and Forecasts by Region

• 2.1 Global Immunology Drug Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Immunology Drug Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Immunology Drug Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Immunology Drug Revenue Market Share by Region (2016-2021)
• 2.3 Global Immunology Drug Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Immunology Drug Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Immunology Drug Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Immunology Drug Estimates and Projections (2016-2027)
  • 2.4.2 Europe Immunology Drug Estimates and Projections (2016-2027)
  • 2.4.3 China Immunology Drug Estimates and Projections (2016-2027)
  • 2.4.4 Japan Immunology Drug Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Immunology Drug Estimates and Projections (2016-2027)
  • 2.4.6 India Immunology Drug Estimates and Projections (2016-2027)

3 Global Immunology Drug Competition Landscape by Players

• 3.1 Global Top Immunology Drug Players by Sales (2016-2021)
• 3.2 Global Top Immunology Drug Players by Revenue (2016-2021)
• 3.3 Global Immunology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunology Drug as of 2020)
• 3.4 Global Immunology Drug Average Price by Company (2016-2021)
• 3.5 Manufacturers Immunology Drug Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Immunology Drug Market Size by Type

• 4.1 Global Immunology Drug Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Immunology Drug Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Immunology Drug Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Immunology Drug Price by Type (2016-2021)
• 4.2 Global Immunology Drug Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Immunology Drug Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Immunology Drug Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Immunology Drug Price Forecast by Type (2022-2027)

5 Global Immunology Drug Market Size by Application

• 5.1 Global Immunology Drug Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Immunology Drug Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Immunology Drug Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Immunology Drug Price by Application (2016-2021)
• 5.2 Global Immunology Drug Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Immunology Drug Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Immunology Drug Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Immunology Drug Price Forecast by Application (2022-2027)

6 North America Immunology Drug Market Facts & Figures

• 6.1 North America Immunology Drug Sales by Company
  • 6.1.1 North America Immunology Drug Sales by Company (2016-2021)
  • 6.1.2 North America Immunology Drug Revenue by Company (2016-2021)
• 6.2 North America Immunology Drug Sales Breakdown by Type
  • 6.2.1 North America Immunology Drug Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Immunology Drug Sales Breakdown by Type (2022-2027)
• 6.3 North America Immunology Drug Sales Breakdown by Application
  • 6.3.1 North America Immunology Drug Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Immunology Drug Sales Breakdown by Application (2022-2027)

7 Europe Immunology Drug Market Facts & Figures

• 7.1 Europe Immunology Drug Sales by Company
  • 7.1.1 Europe Immunology Drug Sales by Company (2016-2021)
  • 7.1.2 Europe Immunology Drug Revenue by Company (2016-2021)
• 7.2 Europe Immunology Drug Sales Breakdown by Type
  • 7.2.1 Europe Immunology Drug Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Immunology Drug Sales Breakdown by Type (2022-2027)
• 7.3 Europe Immunology Drug Sales Breakdown by Application
  • 7.3.1 Europe 127 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 127 Sales Breakdown by Application (2022-2027)

8 China Immunology Drug Market Facts & Figures

• 8.1 China Immunology Drug Sales by Company
  • 8.1.1 China Immunology Drug Sales by Company (2016-2021)
  • 8.1.2 China Immunology Drug Revenue by Company (2016-2021)
• 8.2 China Immunology Drug Sales Breakdown by Type
  • 8.2.1 China Immunology Drug Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Immunology Drug Sales Breakdown by Type (2022-2027)
• 8.3 China Immunology Drug Sales Breakdown by Application
  • 8.3.1 China 154 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 154 Sales Breakdown by Application (2022-2027)

9 Japan Immunology Drug Market Facts & Figures

• 9.1 Japan Immunology Drug Sales by Company
  • 9.1.1 Japan Immunology Drug Sales by Company (2016-2021)
  • 9.1.2 Japan Immunology Drug Revenue by Company (2016-2021)
• 9.2 Japan Immunology Drug Sales Breakdown by Type
  • 9.2.1 Japan Immunology Drug Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Immunology Drug Sales Breakdown by Type (2022-2027)
• 9.3 Japan Immunology Drug Sales Breakdown by Application
  • 9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Immunology Drug Market Facts & Figures

• 10.1 Southeast Asia Immunology Drug Sales by Company
  • 10.1.1 Southeast Asia Immunology Drug Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Immunology Drug Revenue by Company (2016-2021)
• 10.2 Southeast Asia Immunology Drug Sales Breakdown by Type
  • 10.2.1 Southeast Asia Immunology Drug Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Immunology Drug Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Immunology Drug Sales Breakdown by Application
  • 10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Immunology Drug Market Facts & Figures

• 11.1 India Immunology Drug Sales by Company
  • 11.1.1 India Immunology Drug Sales by Company (2016-2021)
  • 11.1.2 India Immunology Drug Revenue by Company (2016-2021)
• 11.2 India Immunology Drug Sales Breakdown by Type
  • 11.2.1 India Immunology Drug Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Immunology Drug Sales Breakdown by Type (2022-2027)
• 11.3 India Immunology Drug Sales Breakdown by Application
  • 11.3.1 India Immunology Drug Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Immunology Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Immunology Drug Business

• 12.1 Abbott Laboratories
  • 12.1.1 Abbott Laboratories Corporation Information
  • 12.1.2 Abbott Laboratories Business Overview
  • 12.1.3 Abbott Laboratories Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Abbott Laboratories Immunology Drug Products Offered
  • 12.1.5 Abbott Laboratories Recent Development
• 12.2 Active Biotech
  • 12.2.1 Active Biotech Corporation Information
  • 12.2.2 Active Biotech Business Overview
  • 12.2.3 Active Biotech Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Active Biotech Immunology Drug Products Offered
  • 12.2.5 Active Biotech Recent Development
• 12.3 Eli Lilly and Company
  • 12.3.1 Eli Lilly and Company Corporation Information
  • 12.3.2 Eli Lilly and Company Business Overview
  • 12.3.3 Eli Lilly and Company Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Eli Lilly and Company Immunology Drug Products Offered
  • 12.3.5 Eli Lilly and Company Recent Development
• 12.4 Autoimmune Inc.
  • 12.4.1 Autoimmune Inc. Corporation Information
  • 12.4.2 Autoimmune Inc. Business Overview
  • 12.4.3 Autoimmune Inc. Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Autoimmune Inc. Immunology Drug Products Offered
  • 12.4.5 Autoimmune Inc. Recent Development
• 12.5 Pfizer
  • 12.5.1 Pfizer Corporation Information
  • 12.5.2 Pfizer Business Overview
  • 12.5.3 Pfizer Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Pfizer Immunology Drug Products Offered
  • 12.5.5 Pfizer Recent Development
• 12.6 GlaxoSmithKline plc
  • 12.6.1 GlaxoSmithKline plc Corporation Information
  • 12.6.2 GlaxoSmithKline plc Business Overview
  • 12.6.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 GlaxoSmithKline plc Immunology Drug Products Offered
  • 12.6.5 GlaxoSmithKline plc Recent Development
• 12.7 Seattle Genetics
  • 12.7.1 Seattle Genetics Corporation Information
  • 12.7.2 Seattle Genetics Business Overview
  • 12.7.3 Seattle Genetics Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Seattle Genetics Immunology Drug Products Offered
  • 12.7.5 Seattle Genetics Recent Development
• 12.8 Genentech
  • 12.8.1 Genentech Corporation Information
  • 12.8.2 Genentech Business Overview
  • 12.8.3 Genentech Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Genentech Immunology Drug Products Offered
  • 12.8.5 Genentech Recent Development
• 12.9 F. Hoffmann-La Roche Ltd.
  • 12.9.1 F. Hoffmann-La Roche Ltd. Corporation Information
  • 12.9.2 F. Hoffmann-La Roche Ltd. Business Overview
  • 12.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Products Offered
  • 12.9.5 F. Hoffmann-La Roche Ltd. Recent Development
• 12.10 Eisai Co.
  • 12.10.1 Eisai Co. Corporation Information
  • 12.10.2 Eisai Co. Business Overview
  • 12.10.3 Eisai Co. Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Eisai Co. Immunology Drug Products Offered
  • 12.10.5 Eisai Co. Recent Development
• 12.11 Bayer AG
  • 12.11.1 Bayer AG Corporation Information
  • 12.11.2 Bayer AG Business Overview
  • 12.11.3 Bayer AG Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Bayer AG Immunology Drug Products Offered
  • 12.11.5 Bayer AG Recent Development
• 12.12 Sanofi Aventis LLC.
  • 12.12.1 Sanofi Aventis LLC. Corporation Information
  • 12.12.2 Sanofi Aventis LLC. Business Overview
  • 12.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Sanofi Aventis LLC. Immunology Drug Products Offered
  • 12.12.5 Sanofi Aventis LLC. Recent Development

13 Immunology Drug Manufacturing Cost Analysis

• 13.1 Immunology Drug Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Immunology Drug
• 13.4 Immunology Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Immunology Drug Distributors List
• 14.3 Immunology Drug Customers

15 Market Dynamics

• 15.1 Immunology Drug Market Trends
• 15.2 Immunology Drug Drivers
• 15.3 Immunology Drug Market Challenges
• 15.4 Immunology Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List